Bausch + Lomb recently announced that its next generation sub-micron gel formulation of loteprednol etabonate was statistically superior to placebo in eliminating inflammation and pain following cataract surgery by study Day 8, the primary endpoints in the first Phase 3, multi-center, double-masked, vehicle-controlled, parallel-group study.
Abbott recently announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for two new products used in laser cataract surgery, the Cataract Operating System 3 (cOS3) and the Liquid Optics Interface 12, both for the company’s Catalys Precision Laser System.
Most of us would probably say that the vast majority of our patients are quite satisfied with the care they receive in our offices. But how do we know this for sure?
Advanced DNA testing for congenital cataracts can quickly and accurately diagnose a number of rare diseases marked by childhood blindness, according to a study published in Ophthalmology.
X-Cel Contacts recently added the Flexlens ARC (Atypical Refractive Correction) custom soft lens to its collection of irregular cornea designs.
Your patients rely on you to help determine if they are good candidates for laser vision correction. We know that a patient’s systemic health can affect the safety and efficacy of refractive surgery.